Discovery and development of allosteric inhibitors of Cdk2/cyclin E as non-toxic ovarian cancer drugs
|Effective start/end date||7/1/23 → 6/30/24|
- MN OVARIAN CANCER ALLIANCE
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.